Tuesday, January 28, 2020 12:12:38 PM
NH NantHealth shares jump on AI-based lung-cancer tool
MarketWatch•January 28, 2020
Shares of NantHealth Inc. soared 56% in premarket trading on Tuesday after the company said it had developed an artificial intelligence software used to improve lung-cancer diagnoses. "With highly accurate tumor-region and lymphocyte detection, oncologists may better treat their patients," NantHealth CEO Dr. Patrick Soon-Shiong said in a news release. Earlier this month, NantHealth said it planned to sell its connected care business to Masimo Corp. for $47.2 million in cash. That deal is expected to close in the first quarter. NantHealth's stock is up 119% over the last 52 weeks, while the Health Care Sector Sector SPDR Fund , an exchange-traded fund, has gained 14%.
MarketWatch•January 28, 2020
Shares of NantHealth Inc. soared 56% in premarket trading on Tuesday after the company said it had developed an artificial intelligence software used to improve lung-cancer diagnoses. "With highly accurate tumor-region and lymphocyte detection, oncologists may better treat their patients," NantHealth CEO Dr. Patrick Soon-Shiong said in a news release. Earlier this month, NantHealth said it planned to sell its connected care business to Masimo Corp. for $47.2 million in cash. That deal is expected to close in the first quarter. NantHealth's stock is up 119% over the last 52 weeks, while the Health Care Sector Sector SPDR Fund , an exchange-traded fund, has gained 14%.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
